Our board

The BIA’s Board is drawn from a wide range of member companies. The Board currently comprises 11 Members, each of whom has been elected for a three-year term, after which they are invited to put themselves forward for re-election.

Board Members

Chair of the Board

Dr Dan Mahony

Dr Dan Mahony

Entrepreneur In Residence, Evotec

Corporate Members

Lisa Anson

Lisa Anson

CEO, Redx Pharma

David Atkins

David Atkins

Managing Partner, BioScience Managers

Charlotte Casebourne

Charlotte Casebourne

CEO, Theolytics

Olivia Cavlan

Olivia Cavlan

Head of Business & Operations, Alchemab

Nicole Farmer

Nicole Farmer

General Manager, Sanofi Genzyme

Oliver Hardick

Oliver Hardick

Entrepreneur In Residence, M Ventures

Prof Jackie Hunter

Prof Jackie Hunter

CEO, OI Pharma Partner, Board Director, BenevolentAI

Dr Ruth McKernan

Dr Ruth McKernan

Chair, Astronautx

Deborah O'Neil

Deborah O'Neil

Chief Executive Officer, NovaBiotics

Dr Mike Romanos

Dr Mike Romanos

CEO, Microbiotica

Nerida Scott

Nerida Scott

Head of Johnson & Johnson Innovation, EMEA, Johnson & Johnson

Sunil Shah

Sunil Shah

CEO, o2h Ventures

Avi Spier

Avi Spier

Executive Director, Novartis Institute for Biomedical Research

Ian McCubbin CBE

Ian McCubbin CBE

Chair of RoslinCT, Chair of Cell and Gene Therapy Catapult

Associate Members

Clare Terlouw

Clare Terlouw

Head of LifeArc Ventures, LifeArc

Dr Peter Finan

Dr Peter Finan

Partner, Epidarex Capital

Ex-Officio

 Steve Bates OBE

Company Secretary

Nick Gardiner

Nick Gardiner

Chief Operating Officer